WELLS FARGO & COMPANY/MN - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is and the CUSIP is 483119202. A total of 25 filers reported holding KALA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$142
-82.3%
16
-70.9%
0.00%
Q2 2023$803
-51.5%
55
-50.0%
0.00%
Q1 2023$1,656
-37.1%
110
+59.4%
0.00%
Q4 2022$2,632690.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Board of Trustees of The Leland Stanford Junior University 21,127$188,0300.02%
Baker Brothers Advisors 266,613$2,372,8560.01%
Covestor Ltd 1,325$120.01%
Knights of Columbus Asset Advisors LLC 2,417$21,5110.00%
MILLENNIUM MANAGEMENT LLC 134,354$1,195,7510.00%
Compagnie Lombard Odier SCmA 400$3,5600.00%
OSAIC HOLDINGS, INC. 234$2,0830.00%
DIMENSIONAL FUND ADVISORS LP 12,092$107,6190.00%
BANK OF AMERICA CORP /DE/ 115$1,0240.00%
WELLS FARGO & COMPANY/MN 16$1420.00%
View complete list of KALA PHARMACEUTICALS INC shareholders